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G-protein-coupled receptors (GPCRs) are known to
possess two different conformations, active and
inactive, and they spontaneously alternate between
the two in the absence of ligands. Here, we analyzed
the agonist-independent GPCR activity for its
possible role in receptor-instructed axonal projec-
tion. We generated transgenic mice expressing
activity mutants of the b2-adrenergic receptor, a
well-characterized GPCR with the highest homology
to odorant receptors (ORs). We found that mutants
with altered agonist-independent activity changed
the transcription levels of axon-targeting mole-
cules—e.g., Neuropilin-1 and Plexin-A1—but not of
glomerular segregation molecules—e.g., Kirrel2 and
Kirrel3—thus causing shifts in glomerular locations
along the anterior-posterior (A-P) axis. Knockout
and in vitro experiments demonstrated that Gs, but
not Golf, is responsible for mediating the agonist-
independent GPCR activity. We conclude that the
equilibrium of conformational transitions set by
each OR is the major determinant of expression
levels of A-P-targeting molecules.
INTRODUCTION
In the mouse olfactory system, various odorants are detected by
1,000 types of odorant receptors (ORs) expressed in the olfac-
tory epithelium (OE) (Buck and Axel, 1991). It is well established
that each olfactory sensory neuron (OSN) expresses only one
functional OR gene in a monoallelic manner (Chess et al.,
1994; Serizawa et al., 2000, 2003). Furthermore, OSNs express-
ing the same type of OR converge their axons to a specific set of1314 Cell 154, 1314–1325, September 12, 2013 ª2013 Elsevier Inc.glomeruli at stereotyped locations in the olfactory bulb (OB)
(Feinstein et al., 2004; Mombaerts et al., 1996; Wang et al.,
1998). Based on these two principles, ‘‘one neuron-one OR’’
and ‘‘one glomerulus-one OR,’’ odor information received in
the OE is represented as a topographic map of activated
glomeruli in the OB (Mori and Sakano, 2011). During develop-
ment, the glomerular map is formed by the combination of OR-
independent and -dependent processes. The dorsal-ventral
(D-V) arrangement of glomeruli is OR independent and is regu-
lated by the anatomical location of OSNs within the OE (Vassar
et al., 1994; Ressler et al., 1994; Miyamichi et al., 2005; Takeuchi
et al., 2010). In contrast, anterior-posterior (A-P) targeting is in-
structed by expressed OR proteins using cyclic AMP (cAMP)
as a second messenger (Chesler et al., 2007; Imai et al., 2006,
2009).
We have previously reported that both global targeting along
the A-P axis and local sorting of OSN axons for glomerular segre-
gation are regulated by OR-derived cAMP (Imai and Sakano,
2008). In the OB, A-P-targeting molecules such as Neuropilin-1
(Nrp1) and Plexin-A1 (PlxnA1) are detected on axon termini of
OSNs, forming a complementary gradient in a glomerular map
(Imai et al., 2006; Imai and Sakano, 2008). OR-derived cAMP
signals also regulate the expression of glomerular segregation
molecules (e.g., Kirrel2 and Kirrel3) for olfactory map refinement
(Serizawa et al., 2006). Unlike A-P-targeting molecules,
glomerular segregation molecules are regulated in a neuronal
activity-dependent manner and show mosaic distribution in the
glomerular map. How is it, then, that A-P targeting and glomer-
ular segregation are differentially regulated by the expressed
ORs although both are under the control of OR-derived cAMP?
What is the source of cAMP signals, and how are the signals
generated? These important questions had never been formally
addressed.
G-protein-coupled receptors (GPCRs), including ORs, are
known to possess two different conformation states, active
and inactive. Agonists stabilize the receptor in an active form,
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Figure 1. OR-Dependent Expression of
Axon Targeting andGlomerular Segregation
Molecules
(A) ACIII-KO mice were analyzed for the expres-
sion of Nrp1, PlxnA1, Kirrel2, and Kirrel3 genes by
quantitative RT-PCR at P14 (left). In the naris
occlusion experiment, one nostril was surgically
occluded at P5, and expression of Nrp1, PlxnA1,
Kirrel2, and Kirrel3 genes in the OE was analyzed
by quantitative RT-PCR at P14 (right). The
contralateral nonoccluded OE was analyzed as a
control (open). *p < 0.01 and **p < 0.001 (Student’s
t test). n.s., not significant. Error bars indicate SD
(n = 3). See also Figure S1A.
(B) Effects of odorant signals on the expression of
glomerular segregation molecules. The transgenic
MOR29B-YFP mice were housed in the presence
or absence of vanillin for 10 days (P21–P31).
Glomerular locations for MOR29B and MOR28
were determined by immunostaining of OB sec-
tions with anti-GFP and anti-MOR28 antibodies,
respectively. Adjacent sections were immuno-
stained with anti-Kirrel2 antibodies. For compari-
son between animals, 300 glomeruli, including
those for MOR28 and MOR29B were measured
and rank ordered for Kirrel2 immunoreactivity.
Four mice were analyzed for each group, and
results from representative animals are shown.
Median intensities = 50. OB sections were also
analyzed with anti-Nrp1 antibodies in the same
way as described above for Kirrel2. On the right,
glomerular ranks (%) are compared for Kirrel2 and
Nrp1 expression in the presence or absence of
vanillin. The ratio of Kirrel2 signals, MOR29B/
MOR28, was significantly increased in the vanillin-
rich condition (3.63) compared to the control (1.84)
(n = 4 mice for each group, *p < 0.01, Student’s t
test). n.s., not significant. Error bars indicate SEM.
(C) Targeting and sorting of MOR10-expressing
axons in the Kir2.1-overexpressing mouse (Kir2.1
OEx). Kir2.1 OEx was analyzed for the expression
of Nrp1 and Kirrel2 genes by quantitative RT-PCR
at P3. Relative expression levels are shown in left
panel. Error bars indicate SD (n = 3). Whole-
mount views of the lateral aspect of the OBs
visualized by the fluorescence of EYFP are shown in the middle. In the Kir2.1 OEx, MOR10 glomeruli are scattered and more diffused. However, glomerular
locations along the A-P axis are unaffected (summarized on the right). Mice were analyzed at P14. A, anterior; P, posterior. Error bars indicate SD (n = 8). See also
Figure S1B.whereas inverse agonists stabilize it in an inactive form (Bond
and Ijzerman, 2006; Kobilka and Deupi, 2007). In the absence
of agonists and inverse agonists, GPCRs produce a baseline
level of cAMP by spontaneously flipping between active and
inactive conformations. For different OR species, variable but
specific levels of constitutive activities have been reported
(Kato et al., 2008; Reisert, 2010). In humans, a number of exam-
ples of endocrine diseases are known where the agonist-inde-
pendent receptor activity is elevated by mutations in GPCRs
(Vassart and Costagliola, 2011). However, the agonist-indepen-
dent activity had long been considered to be noise created by
GPCRs, and its functional role was not fully appreciated. Here,
we study the possible role of agonist-independent GPCR activity
in the receptor-instructed axonal projection.CRESULTS
Signaling Natures for OR-Instructed Axonal Projection
In the canonical signal transduction pathway, ORs couple to a
heterotrimeric G protein, Golf, converting guanosine diphosphate
(GDP) to guanosine triphosphate (GTP) (Imai and Sakano, 2008).
The GTP-bound Golf, then stimulates adenylyl cyclase type III
(ACIII), leading to cAMP production. In the knockout (KO) mouse
deficient for ACIII, Nrp1 and Kirrel2 expression was downregu-
lated (Col et al., 2007), whereas PlxnA1 and Kirrel3 expression
was upregulated (Figures 1A, S1A, and S1C available online).
Interestingly, expression levels of glomerular segregation mole-
cules (e.g., Kirrel2 and Kirrel3) were affected by unilateral naris
occlusion. In the occluded naris, Kirrel2 was downregulatedell 154, 1314–1325, September 12, 2013 ª2013 Elsevier Inc. 1315
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Figure 2. Activity Mutants of b2-AR
(A) Conformational changes of b2-AR. GPCRs are known to possess two different conformations, active and inactive (left, modified from Rasmussen et al.
[2011a]). Agonists lock the receptor structure in an active form, whereas inverse agonists stabilize the receptor in an inactive form (upper right). In the absence of
ligands, GPCRs spontaneously interchange between the two conformations, active and inactive, generating agonist-independent baseline activity (lower right).
(B) Activity mutants of b2-AR. To generate mutants, amino acid residues in the ligand-binding domain or in the cytoplasmic domain were changed or deleted by
site-directed mutagenesis. These mutants were analyzed for both agonist-independent activity (left) and agonist-dependent activity (right) by the luciferase
assay. Among the b2-AR mutations analyzed, some affected only one of the two activities, either agonist-dependent activity (shaded) or agonist-independent
activity (gray). The wild-type b2-AR was analyzed as a standard (black). Vector alone was analyzed as a control. Relative activities are shown in bar graphs after
the normalization to the WT baseline activity (1). Error bars indicate SD (n = 8).
(C) Normalization of activities. Measured agonist-independent activities (left) were normalized to the membrane expression levels of b2-AR (right). N-terminal
FLAG-tagged b2-ARs were expressed by the CMV promoter, and transfected cells were immunostained with anti-FLAG antibody. Membrane expression of b2-
ARs in HEK293 cells was quantified by FACS analysis (middle). The agonist-independent activity of WT b2-AR was used as a standard. *p < 0.01 and **p < 0.001
(Student’s t test). Error bars indicate SD (n = 8). See also Figure S2C.
(D) Schematic diagrams of activity generation bymutant b2-ARs. The C327R (red) contains amutation at residue 327, replacing cysteine with arginine andmaking
the entry tract for G protein narrower. The D267–273 (orange) exhibits decreased agonist-independent activity due to the deletion of key residues that constitute
the G protein entry gate. The E268A (green) generates increased agonist-independent activity. The residue change from glutamic acid to alanine at position 268
removes the negative charge at the bottom of b2-AR, and loss of the ionic interaction with arginine at 131 makes the G protein entry gate much looser.and Kirrel3 was upregulated, whereas transcription of A-P-
targeting genes, Nrp1 and PlxnA1, was not affected (Figures
1A, S1A, and S1C). These results indicate that stimulus-driven
activity contributes to the local sorting of OSN axons for glomer-
ular segregation but does not affect global targeting along the
A-P axis.
We examinedwhether odorous stimuli can change the expres-
sion profile of A-P targeting and glomerular segregation mole-
cules (Figure 1B) using the bacterial artificial chromosome
(BAC) transgenic mouse in which the MOR29B gene is tagged
with IRES-gapEYFP. The transgenic mice were housed in the
presence of vanillin, a ligand for MOR29B (Tsuboi et al., 2011),
for 10 days. In control mice not exposed to vanillin, MOR29B
glomeruli ranked in the 30th percentile from the lowest Kirrel2-
staining intensity among 300 glomeruli analyzed. In contrast,
when the mice were exposed to vanillin, the ranking went up to
60th percentile from the lowest. Ranking did not change for the
control OR, MOR28, in the same animal. Interestingly, Nrp1
expression was not affected by vanillin exposure in the
MOR29B-positive OSNs. These results indicate that the expres-
sion of glomerular segregation molecules is regulated by ligand-1316 Cell 154, 1314–1325, September 12, 2013 ª2013 Elsevier Inc.induced signals, whereas the expression of A-P-targeting mole-
cules is likely to be driven by ligand-independent activity.
It has been reported that overexpression of the inward-recti-
fying potassium channel Kir2.1 hyperpolarizes neurons and
thus completely inhibits the generation of action potentials
(Johns et al., 1999). In the Kir2.1-overexpressing mouse (Yu
et al., 2004), Kirrel2 was downregulated, but Nrp1 expression
was not affected (Figures 1C and S1B). We analyzed the
glomerular formation in the Kir2.1 mutant mouse. The glomerular
structure became more diffuse than normal, but A-P targeting
was unaffected (Figure 1C). The Kir2.1 experiments reveal that
neuronal firing is not responsible for OR-instructed A-P
targeting. What kind of activity regulates A-P targeting, then?
Receptor Mutants for Agonist-Independent Activity
It has been reported that GPCRs spontaneously alternate
between two different conformational states, active and inactive,
thereby generating unique levels of cAMP in the absence of
agonists and inverse agonists (Bond and Ijzerman, 2006; Kobilka
and Deupi, 2007; Reisert, 2010) (Figure 2A). We hypothesized
that the agonist-independent OR activity may participate in the
regulation of A-P targeting of OSN axons. In order to examine
this possibility, we attempted to generate the activity mutants
of GPCRs. The initial experiment with ORs was not successful
due to the challenges of achieving adequate membrane expres-
sion in the heterologous system. In addition, due to the vast
diversity of OR family proteins and the lack of three-dimensional
(3D) structural information, prediction and screening of activity
mutants were difficult for OR molecules. In contrast, b2-adren-
ergic receptor (b2-AR), a GPCR with the highest sequence
homology to ORs, is easier to express in transfected cells and
shares many functional similarities with ORs. When expressed
in OSNs with the OR gene promoter, b2-AR maintains the one
neuron-one receptor rule, couples with the a subunit of Gs or
Golf, and substitutes ORs for receptor-instructed axonal projec-
tion (Feinstein et al., 2004). Furthermore, b2-AR has advantages
of being well characterized for distinct receptor functions. Based
on mutational studies, the key amino acid residues in the b2-AR
that are required for G protein coupling, ligand binding, and the
generation of agonist-independent activity are well character-
ized (Ballesteros et al., 2001; O’Dowd et al., 1988; Savarese
and Fraser, 1992). Recently, the 3D structures of b2-AR in its
active state and in a complex with a stimulatory G protein have
been determined (Rasmussen et al., 2011a, 2011b) (Figure 2A,
left). As a result of these favorable features, we selected b2-AR
for the transgenic analysis of the agonist-independent GPCR
activity in axonal projection of OSNs.
In addition to b2-AR mutations previously described (Balles-
teros et al., 2001; O’Dowd et al., 1988; Savarese and Fraser,
1992), we introduced new mutations in the ligand-binding extra-
cellular domain and G-protein-interacting transmembrane
region. For these b2-AR mutants, we measured agonist-
independent and agonist-dependent activities in the transfected
human embryonic kidney (HEK)293 cell lines, where cAMP was
quantified using aCRE-luc reporter assay (Saito et al., 2009; Tsu-
boi et al., 2011) (Figure 2B). For thewild-type (WT)b2-AR, the level
of agonist-independent activitywasoneorder ofmagnitude lower
than that of agonist-dependent activity. Among the b2-AR muta-
tions analyzed, some affected both agonist-independent and
agonist-dependent activities, whereas others affected only one
of the two activities.We predict thatmutations affectingGprotein
activation—e.g., DRYmotifmutations—would alter both agonist-
dependent and -independent activities, whereas those altering
ligand interactions would change agonist-dependent activity.
Mutations that affect equilibrium of conformational transitions
should alter the agonist-independent receptor activity.
For further transgenic studies, we selected three b2-AR
mutants from the collection, which significantly altered agonist-
independent receptor activity, but not the agonist-dependent
activity (Figure 2C). The C327R contains a mutation at residue
327, replacing cysteine with arginine. Based on the 3D structural
analysis (Rasmussen et al., 2011a, 2011b), we predict that this
change makes entry tract for G protein narrower, thus lowering
the agonist-independent activity to one-third that of the WT (Fig-
ure 2D, upper right). The D267–273 exhibits decreased agonist-
independent activity due to the deletion of key residues that
constitute the G protein entry gate (Figure 2D, lower left). In
contrast, the E268A has increased agonist-independent activity
more than 3-fold that of WT. This mutation, changing the residueCfrom glutamic acid to alanine at position 268, removes the nega-
tive charge at the bottom of b2-AR. Loss of the ionic interaction
with arginine at 131 breaks a lock on the entry gate for the G pro-
tein, making it looser (Figure 2D, lower right). This likely increases
the frequency of turnover of G protein coupling to b2-AR, gener-
ating a higher level of agonist-independent activity. It is impor-
tant to make certain that activity alterations are not due to
changes in membrane expression of mutant protein. To confirm,
we immunostained transfected HEK293 cells with antibodies
against FLAG, an N-terminal epitope tag, and found that mutant
receptors were detected on the cell surface at levels comparable
to that of WT (Figure S2C). Membrane expression of b2-ARs was
quantified by fluorescence-activated cell sorting (FACS)
analysis. Measured agonist-independent activities were normal-
ized to the surface expression levels for further studies.
Transgenic Analyses of b2-AR Mutants
We then generated transgenicmice expressing themutant orWT
b2-AR using an OR gene promoter. This was performed by
replacing the MOR23 coding sequence with that of b2-AR in
the MOR23 minigene cassette (Figure S2A). We first checked
b2-AR expression in OSNs of the transgenic mice. OE sections
were isolated and stained with antibodies against b2-AR. Both
the WT and mutant b2-ARs reacted equally to the b2-AR anti-
bodies with no notable differences in their staining levels (Fig-
ure S2B, left). The level of mutant protein expression quantified
by FACS was not affected by the mutations in the transgenic
mice (Figure S2B, right).
We next studied the glomerular locations in the OB for the
mutant b2-ARs tagged with enhanced yellow fluorescent protein
(EYFP) (Figure 3A). At least four independent transgenic mouse
lines were generated for each b2-AR mutant. OSNs expressing
the WT b2-AR tagged with ECFP generated a glomerulus
halfway along the A-P axis of the OB (Figure 3A, left) and formed
synapses with mitral cell dendrites (Figure S2D). To compare
glomerular locations of mutant b2-ARs with that of the WT within
the same animal, we crossed one of the WT b2-AR transgenic
lines with each mutant line. The activity-low mutant, C327R
(30% of WT), generated glomeruli (red) anterior to that of the
WT (white). The shift was minor for another activity-low mutant,
D267–273 (75% ofWT) (Figure 3A, middle). In contrast, the activ-
ity-high mutation, E268A (350% of WT), caused a posterior shift
of glomeruli (green) (Figure 3A, right). This finding shows a good
correlation between the agonist-independent activities of
b2-ARs and their corresponding glomerular locations along the
A-P axis (Figures 3B and 3C).
We also examined the expression levels of A-P-targeting mol-
ecules in the b2-AR glomeruli by immunostaining and performing
quantitative PCR (qPCR) of FACS-sorted OSNs. As shown in
Figure 4A, Nrp1 expression in b2-AR-expressing OSNs was
increased by the activity-high mutation, E268A, but lowered by
the activity-low mutations, C327R and D267–273. In contrast,
PlxnA1 expression was downregulated by E268A but upregu-
lated by C327R and D267–273. It is notable that expression
levels of glomerular segregation molecules, e.g., Kirrel2 and
Kirrel3, were not affected at all by these mutations (Figure 4B).
Above observations, together with the result of naris occlusion
(Figures 1A, right, and S1A, middle), suggest that A-P-targetingell 154, 1314–1325, September 12, 2013 ª2013 Elsevier Inc. 1317
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Figure 3. Agonist-Independent Activity
Regulates A-P Positioning of Glomeruli
(A) Location of glomeruli for theWT andmutant b2-
ARs. Activity-low mutants, C327R and D267–273
(red and yellow), exhibited anterior shifts of
glomeruli (two middle panels), whereas the activ-
ity-high mutant, E268A (green), exhibited a pos-
terior shift (right). TheWT b2-AR glomerulus (white)
was used as a positional control within the same
animal. Location of glomeruli in the medial OB was
determined by CFP (WT) or YFP (mutants) fluo-
rescence, respectively. Enlarged photos are
shown in bottom. Schematic diagrams are on top.
Scale bars, 500 mm. Mice were analyzed at P14.
(B) Agonist-independent activities for mutant b2-
ARs. Activities were measured for the WT and
mutant b2-ARs using the luciferase assay (left).
Relative activities are shown in a bar graph using
the WT activity as a standard (1). Vector alone was
analyzed as a control. *p < 0.01 and **p < 0.001
(Student’s t test). Error bars represent SD (n = 8).
(C) Glomerular locations are summarized for the
WT and mutant b2-ARs along the A-P axis on the
medial surface of the OB (right). n = 12 for each
strains. *p < 0.01 and **p < 0.001 (Student’s t test).
Error bars represent SD. See also Figure S2.molecules and glomerular segregation molecules are separately
regulated by two distinct OR-derived signals.
To examine whether the correlation between the agonist-inde-
pendent activities and glomerular locations holds true for natural
ORs, we performed the following experiments. We dissected the
mouse OB into three sections: anterior, middle, and posterior.
Thirty OR genes were cloned, transfected into HEK293 cells,
and analyzed for their activities without ligands by the luciferase
assay (Figure 5A). To facilitate cell-surface expression of OR
molecules, we cotransfected a chaperone protein gene RTP1S
into HEK293 cells (Saito et al., 2004). The activity ranged
from 0.37 ± 0.12 for MOR215-1 to 5.33 ± 0.35 for MOR 259-11
using the MOR-EG activity as a standard. ORs cloned from the
anterior OB produced relatively lower levels of agonist-indepen-
dent activities (0.67 ± 0.21, mean ± SEM, n = 8), and those from
the posterior OB generated higher levels (2.34 ± 1.34, mean ±
SEM, n = 8). For natural ORs, the promoter activities, protein sta-
bilities, and membrane transport could be potential factors
affecting total cAMP signal levels. We therefore measured
cell-surface expression of MOR215-1, MOR37b, MOR-EG,
MOR103-1, MOR256-17, and MOR259-11 by immunostaining
and FACS analysis. At least among these ORs, differences
were within 15% (Figure S3B), although greater differences
were found for some other ORs in a separate experiment (Fig-1318 Cell 154, 1314–1325, September 12, 2013 ª2013 Elsevier Inc.ure S4D). In any case, the agonist-inde-
pendent receptor activity is the major
determinant of expression levels of A-P-
targeting molecules.
To confirm the link of OR activity/axon
guidance molecule/glomerular location,
we generated knockin mice in which the
coding sequence of MOR215-1 hadbeen replaced with that of MOR103-1 to maintain the same
levels of transcription. In Figure 5B, levels of A-P projection mol-
ecules, glomerular locations, and agonist-independent activities
were compared between MOR215-1 and MOR103-1 expressed
by the sameMOR215-1 promoter in vivo and the CMV promoter
in vitro. Anterior MOR215-1 with the lower agonist-independent
activity demonstrated Nrp1low/PlexnA1high expression, whereas
posterior MOR103-1 with the higher activity showed Nrp1high/
PlexnA1low expression.
Differential Usage of Gs and Golf in OSNs
Our results demonstrated that OR-instructed A-P targeting and
glomerular segregation are differentially regulated by two
distinct OR-derived cAMP signals. How are these two types of
regulation separately controlled during development? To
address this question, we studied the onset of expression for
various genes involved in axon guidance and signal transduction
in OSNs. OE sections from different developmental stages were
analyzed by in situ hybridization using GAP43 and OMP probes
as immature and mature OSN markers, respectively (Figures
S5C and S5D). At embryonic day (E) 13.5, immature OSNs start
to appear, and mature OSNs are found at E17.5. At E13.5,
hybridization signals were detected for A-P-targeting molecules
(e.g., Nrp1), but not for glomerular segregation molecules
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Figure 4. Agonist-Independent Activity Regulates the Expression of A-P-Targeting Molecules
(A) Immunostaining of OB sections. A-P-targeting molecules were affected by agonist-independent activity mutations. b2-AR-positive glomeruli were identified
with anti-GFP antibodies. Adjacent sections were stained with anti-Nrp1 and anti-PlxnA1 antibodies. The C327R (activity-low) mutation lowered Nrp1 expression
but increased PlxnA1. In contrast, Nrp1 was upregulated and PlxnA1 was downregulated by the E268A (activity-high) mutation. Relative expression levels of
protein andmRNA are normalized to theWT and compared in bar graphs. Correlations between the A-P projection molecules and agonist-independent activities
are shown on the right. Mice were analyzed at P14. *p < 0.01 and **p < 0.001 (Student’s t test). Error bars represent SD (n = 8).
(B) Glomerular segregation molecules were not affected by the agonist-independent activity mutations. b2-AR glomeruli were detected with anti-GFP antibodies.
Adjacent OB sections were stained with anti-Kirrel2 and anti-Kirrel3 antibodies. Mice were analyzed at P14. Error bars represent SD (n = 8).(e.g., Kirrel2). Kirrel2 expression became prominent only at the
late stage of embryonic development. We also analyzed the
onset of Gs, Golf, phosphodiesterases (PDEs), and other signal
transduction molecules. Hybridization signals were detected
for Gs at E13.5. In contrast, Golf and PDE genes were expressed
at E17.5, but not at E13.5, indicating that Golf and PDEs are not
required for the expression of A-P-targeting molecules. High
PDE expression in mature OSNs may help to detect precise
temporal changes of OR-derived cAMP signals by erasing the
noise-level activity.
Gs and Golf are structurally similar, sharing 88% amino acid
identity. Both mediate OR signals and activate ACIII in OSNs;
however, their functional differences in the cellular context are
not fully recognized. What could be the reason that Gs and Golf
are differentially expressed in OSNs during development? We
examined the biochemical properties of Gs and Golf in mediating
OR signals. Interactions of GPCR and G proteins are often
studied using GPCR::Ga fusion proteins because it ensures 1:1
stoichiometry of GPCR-Ga interactions and minimizes the inter-
actions with endogenously expressed G proteins (Milligan,
2000). We generated Gs and Golf fusion proteins for MOR29B,
MOR106-1, and MOR223-1, whose agonists have been estab-
lished (Saito et al., 2009; Tsuboi et al., 2011). Both agonist-
independent and -dependent cAMP signals were measured by
the dual luciferase assay using b2-AR as a control (Figures 6
and S4). We detected much higher agonist-independent activ-Cities with Gs than with Golf, whereas ligand response properties
were similar between Gs and Golf. As a result, the ratio of
maximum stimulus response to the agonist-independent activity
was higher with the fusion protein of Golf than that of Gs. It is
notable that expression levels of OR::Gs and OR::Golf proteins
were comparable in this experiment. Similar results were also
obtained with coexpressed OR molecules and G proteins (Fig-
ure S4B). We conclude that Gs mediates agonist-independent
activity more efficiently than Golf.
Our observations are consistent with the earlier biochemical
characterization that Golf possesses lower GDP affinity and is
more rapidly deactivated by its high GTPase activity (Liu et al.,
2001; Seifert et al., 1998). In regulating axonal projection of
OSNs, Gs-mediated activity may be useful for ORs whose
cognate ligands are not available during embryonic develop-
ment. Variable levels of agonist-independent baseline-level
activity can be detected with Gs for different ORs in HEK293 cells
(Figure S4D).
Knockout Analyses of Gs and Golf
To further study the differential functions of Gs and Golf, we per-
formed loss-of-function experiments by using mutant mice.
Conventional Gs-KO dies before E10.5, precluding studies of
early olfactory development (Yu et al., 1998). We generated the
dorsal OE-specific conditional knockout (CKO) for Gs using the
omacs-cre driver (Kobayakawa et al., 2007) and floxed-gnasell 154, 1314–1325, September 12, 2013 ª2013 Elsevier Inc. 1319
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Figure 5. Agonist-Independent Activities of
Various ORs
(A) Thirty OR genes were cloned from three OB
sections frommice at P14, anterior (green), middle
(gray), and posterior (red) and were transfected to
HEK293 cells. Agonist-independent activities were
measured by the luciferase assay. Relative activ-
ities are plotted (bottom). The agonist-indepen-
dent activity of MOR-EG was used as a standard.
Green and red squares represent the means ±
SEM for the anterior and posterior ORs, respec-
tively. Glomerular locations for some ORs are
shown in a schematic diagram of the medial OB
(top). (Mann-Whitney U test = 186.00; p = 0.05).
See also Figure S3.
(B) Agonist-independent OR activities and
expression levels of A-P-targeting molecules. Two
knockin mouse strains were analyzed—one is
MOR215-1-EGFP, and the other is MOR103-1/
MOR215-1-ECFP, in which the coding sequence
of MOR215-1 was replaced with that of
MOR103-1. To measure agonist-independent
activities in vitro using the luciferase assay,
MOR215-1 and MOR103-1 were expressed in
HEK293 cells under the CMV promoter. In the in vivo experiment, the same MOR215-1 promoter was used for both MOR215-1 and MOR103-1 expression to
maintain the same levels of transcription. Expression levels (immunostaining) of Nrp1 and PlxnA1 and agonist-independent OR activities are compared between
MOR215-1 andMOR103-1/MOR215-1 (upper right). Coronal OB sections were immunostained with anti-GFP antibodies to detect glomeruli for the knockin OR
alleles. Adjacent sections were immunostained with anti-Nrp1 or anti-PlxnA1 antibodies (bottom). Glomerular locations of MOR215-1-EGFP and MOR103-1/
MOR215-1-ECFP are shown in a diagram (upper left). Mice were analyzed at P14. **p < 0.001 (Student’s t test). Error bars represent SD (n = 8). i indicates an
internal ribosome entry site (IRES).mouse lines (Chen et al., 2005). In order to study differential re-
quirements of G proteins, we analyzed G protein KO mice for
the expression of A-P targeting (e.g., Nrp1) and glomerular
segregation molecules (e.g., Kirrel2). It has been reported that
Golf is essential for generating odor-evoked neuronal activity
but is dispensable for regulating OSN projection in neonatal
mice (Belluscio et al., 1998). Consistent with this earlier study,
Nrp1 expression was not affected in the Golf-KO (Figures 7A
and S5A). In the neonatal Gs-CKO, however, Nrp1 expression
was diminished in the dorsal OB. In contrast, Kirrel2 expression
was abolished in theGolf-KO but was not affected in theGs-CKO.
Due to the variability of Nrp1 expression with different ORs, we
focused our analyses on OSNs expressing the CFP-tagged OR
transgene, rat I7 (rI7)-CFP, expressed with the dorsal-zone-
specific MOR23 promoter (Imai et al., 2006). As shown in Fig-
ure S5B, Nrp1 immunoreactivity was prominent in rI7-CFP-
expressing OSNs in both WT and Golf-KO mice but was greatly
reduced in the Gs-CKO at postnatal day (P) 0. In the Gs-CKO/
Golf-KO double mutant, Nrp1 expression was completely abol-
ished in all dorsal-zone axons (Figure S5A). Thus, Gs is required
for normal Nrp1 expression, whereas Golf is compensatory in
some OSN populations. We examined axonal projection and
glomerular formation for rI7-CFP (Figure 7B). In the Gs-CKO
mice, rI7-CFP-expressing OSNs mistargeted to the anterior
OB, often forming diffused clusters of glomeruli, indicating that
Gs mediates the baseline activity necessary for the regulation
of A-P-targeting molecules. In contrast, Golf-KO produced a
similar projection profile to that of the WT at the neonatal stage.
This is probably because Gs compensates the Golf function, at
least in part, in the Golf-KO. Supporting this idea, in the1320 Cell 154, 1314–1325, September 12, 2013 ª2013 Elsevier Inc.Gs-CKO/Golf-KO double mutant, most rI7-positive axons remain
in the anterior OB, failing to form glomerular structures (Fig-
ure 7B). This phenotype is quite similar to that found with the
DRY-motif mutant of rI7, which blocks both Gs- and Golf-medi-
ated signals (Imai et al., 2006). Taken together, our results
demonstrate that Gs plays amajor role in regulating A-P targeting
in immature OSNs, followed by the role of Golf for glomerular
segregation in mature OSNs.
DISCUSSION
The olfactory map is established by a combination of genetically
determined global targeting and activity-dependent local sorting
of OSN axons during development (Chen and Flanagan, 2006;
Imai and Sakano, 2008). Activity-dependent refinement, which
follows initial targeting, plays an important role in many other
sensory systems (Feldheim and O’Leary, 2010; Luo and Flana-
gan, 2007). In the mouse olfactory system, coarse map topog-
raphy is established by the combination of OR-dependent
and -independent processes. The A-P targeting is instructed
by OR-derived cAMP, whereas the D-V targeting is regulated
by the anatomical locations of OSNs within the OE. These pro-
cesses are genetically programmed and independent from the
neuronal activity (Sakano, 2010). After OSN axons reach the
OB, further refinement occurs in an activity-dependent manner
through fasciculation of axon termini and glomerular segregation
(Serizawa et al., 2006).
Our present study revealed that A-P targeting and glomerular
segregation are separately regulated by distinct signals that both
rely on OR-derived cAMP as a second messenger. These two
ORs
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Figure 6. Luciferase Assay of GPCR Activities In Vitro
(A) Agonist-independent activities of b2-AR and ORs. Agonist-independent
OR activity was measured in the transfected HEK293 cells using the dual
luciferase assay (see Experimental Procedures for details). b2-AR was
analyzed as a positive control. To ensure the OR-Ga coupling, coding
sequences of OR and Ga were fused with a flexible linker sequence. Data are
mean ± SEM (n = 3 for each).
(B) Agonist-dependent activities of b2-AR and ORs. OR activity induced by
ligand stimulation was measured in the transfected HEK293 cells using the
dual luciferase assay. For b2-AR and three OR species (MOR29B, MOR106-1,
and MOR223-1), higher agonist-independent activities were detected with Gs
(red) than with Golf (blue), although ligand response properties were com-
parable between them. The ratio of maximum fold response to agonist-
independent activity, i.e., maximum response/ agonist-independent activity,
was higher with the fusion protein of Golf than that of Gs. Data are mean ± SEM
(n = 3 for each). See also Figure S4.types of OR signals are transduced at different stages of olfac-
tory development (Figure 7C). Furthermore, the differences
between the two types of regulation may also be due to the sub-
cellular localization of ORs, namely, cilia in mature OSNs versus
axon termini in immature OSNs. Although spatial and temporal
insulation of the two distinct OR signals may explain the differen-Ctial regulation of A-P targeting and glomerular segregation mole-
cules, the major basis for the difference in distribution of the two
types of molecules in the map, graded versus mosaic, is a result
of the distinct sources of their cAMP signals. Our present study
demonstrates that the equilibrium of conformational transition of
GPCRs without ligands determines the steady-state levels of
cAMP in immature OSNs, which ultimately determine the
expression levels of A-P-targeting molecules. In contrast,
expression of glomerular segregation molecules is regulated
by the stimulus-driven neuronal activity in mature OSNs (Fig-
ure 7C). Amounts of stimuli appear to be the major determinants
of the expression levels of glomerular segregation molecules.
OR-specific rate-limiting factors of cAMP production are
different between the agonist-independent and -dependent pro-
cesses. Thus, it is conceivable that rank orders of ORs become
different for the agonist-independent and -dependent processes
of cAMP production.
Using dissociated OSNs, intrinsic neuronal activity has
been detected in the absence of odorous ligand (Reisert,
2010). In the visual system, spontaneous firing waves in the
retina play a crucial role in shaping the neuronal map during
the critical period in the first 1 to 2 postnatal weeks (Feller,
2002; McLaughlin et al., 2003; Penn et al., 1998). Therefore, it
has been thought that the intrinsic neuronal activity in the olfac-
tory system may play roles in the olfactory map formation (Con-
nelly et al., 2013; Reisert, 2010). Although such activity may be
involved in the regulation of glomerular segregation, it is unlikely
that the intrinsic neuronal activity influences the A-P targeting.
This is because the expression of A-P-targeting molecules is
not affected by naris occlusion or by Kir2.1 overexpression.
Some ORs may generate high enough baseline activities that
activate the canonical signal transduction pathway. However,
the activity-high mutant, E268A, did not affect the expression
of glomerular segregation molecules at all (Figure 4B). Thus, it
is unlikely that the agonist-independent OR activity is the source
of the intrinsic neuronal activity. The intrinsic OSN activity
appears to be generated by the canonical signaling pathway
using Golf and CNG channels and probably requires promiscu-
ous activation of the ligand-interaction site in ORs. It has been
assumed that endogenous ligands in the amniotic fluid may
influence the olfactory map formation in the fetus (Coppola
and O’Connell, 1989). Because our present study demonstrates
that A-P targeting is not influenced by OR ligands (Figure 1B), it
is unlikely that the intrinsic ligands in the amniotic fluid affect the
A-P targeting.
Gs and Golf are structurally similar, sharing high amino acid
identity. Furthermore, both mediate OR signals and activate
ACIII in OSNs. However, their functional differences in the
cellular context have not been fully recognized. In the present
study, we found that Gs detects GPCR baseline activity
more efficiently, generating higher cAMP than Golf, although
dose-response properties are similar (Figures 6 and S4). How
can Gs and Golf selectively transduce agonist-independent
and -dependent activities, respectively? In immature OSNs,
CNG channels are not yet expressed and OR baseline activ-
ities are transduced by Gs to produce cAMP that leads to pro-
tein kinase A (PKA) activation. Steady-state levels of cAMP
determine the transcription levels of A-P-targeting moleculesell 154, 1314–1325, September 12, 2013 ª2013 Elsevier Inc. 1321
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Figure 7. Differential Effects of Gs-CKO and
Golf-KO on OSN Projection
(A) Quantification of Nrp1 and Kirrel2 in theOB of G
protein KO mice. Horizontal sections of the OB
were immunostained with antibodies against
Nrp1, OMP, and Kirrel2 (left). Staining intensities
were quantified using Scion Image (Scion Corpo-
ration; see Experimental Procedures for detail) and
normalized to the WT level as a standard. The
number of OMP-positive mature OSNs was
reduced in the Gs-CKO/Golf-KO. Mice were
analyzed at P0. Expression of Nrp1 and Kirrel2
were also analyzed specifically for rat I7 (rI7)
glomeruli in the KO mice. Basically the same re-
sults were obtained as with the entire OB section.
*p < 0.01 and **p < 0.001 (Student’s t test). Error
bars represent SD (n = 4). See also Figure S5.
(B) Glomerular formation and location in the KO
mice. CFP-tagged rat I7 (rI7) glomeruli were
analyzed at P0. Horizontal OB sections (top) were
stained with anti-CFP antibodies (green) and
counterstained with DAPI (blue). Dotted lines mark
the border of OBs. Medial views of the OB at P3
are shown (bottom). In the double KO, rI7 axons
remain in the anterior OB, failing to form glomerular
structure (n = 6). A, anterior; P, posterior; D, dorsal;
V, ventral; L, lateral; and M, medial.
(C) Canonical and noncanonical signal trans-
duction pathways for OR-derived activities. In
immature OSNs (left), each OR species generates
a unique level of agonist-independent activity,
which is converted to the cAMP signals with the
aid of Gs and ACIII. The level of cAMP signals
determines expression levels of A-P-targeting
molecules—e.g., Nrp1 and PlxnA1—using the
cAMP-activated PKA pathway. In mature OSNs
(right), the stimulus-driven OR signals open ion
channels, generating neuronal activity that regu-
lates expression levels of glomerular segregation
molecules, e.g., Kirrel2 and Kirrel3. Temporal
changes of OR-derived cAMP signals are con-
verted to unique firing patterns with the aid
of PDEs.via PKA. In mature OSNs, stimulus-driven or ligand-induced
OR activities are transduced by Golf, resulting in a high-level
of cAMP that activates CNG channels. It has been reported
that Golf possesses a higher turnover rate of GTP to GDP
compared with Gs (Liu et al., 2001; Seifert et al., 1998). These
characteristics of Golf, together with the presence of PDEs, are
well adapted to precisely detect temporal changes of cAMP
signals in mature OSNs. Temporal regulation of G protein
expression—Gs in immature and Golf in mature OSNs—is
important to separate two olfactory signaling pathways, non-
canonical and canonical, during development (Figure 7C).
Agonist-independent activity had long been regarded as
baseline noise created by GPCRs, and its biological role was1322 Cell 154, 1314–1325, September 12, 2013 ª2013 Elsevier Inc.not fully appreciated. However, recent
studies of crystal structures and mole-
cular dynamics have revealed the inner
workings of various GPCRs (Nygaard
et al., 2013; Rasmussen et al., 2011a,2011b; Rosenbaum et al., 2009). The extracellular cavity deter-
mines ligand specificity, whereas the intracellular cavity deter-
mines G protein selectivity and levels of GPCR baseline
activities. The olfactory systemmakes use of the extensive func-
tionality of the largest family of GPCRs. The variability in the
extracellular cavity of ORs contributes to the recognition of a
vast diversity of odor ligands, and the diversity in the intracellular
loops contributes to the generation of variable but specific levels
of OR baseline activities.
After 22 years since the discovery of the OR-gene (Buck and
Axel, 1991), it is now clear what defines the identity of OSNs in
OR-instructed axonal projection. Our present studies have
revealed that the equilibrium of conformational transitions set
by each OR is what determines the transcription levels of A-P-
targeting molecules in OSNs.
EXPERIMENTAL PROCEDURES
Mutant Mice
ACIII-KO mouse, MOR10-tagging mouse, and Kir2.1-overexpressing mouse
are described previously (Takeuchi et al., 2010; Wong et al., 2000; Yu et al.,
2004). To generate a MOR23 minigene construct, a 10.1 kb SacI fragment
containing the MOR23 gene from a BAC clone of C57BL/6 mouse (RP23-
306I18) was subcloned into pBluescript II SK(+). The 930 bp coding sequence
of MOR23 was replaced with that of b2-AR. The SacII fragment containing
IRES-gapECFP or IRES-gapEYFP was inserted downstream of b2-AR. Trans-
gene sequences were excised by BssHII digestion, separated from the vector
DNA by sucrose gradient centrifugation, and then microinjected into the
pronuclei of C57BL/6 embryos.
OMACS-Cre knockin (Kobayakawa et al., 2007) and Gs floxed (Chen et al.,
2005)micewere previously reported. Golf-KO (Belluscio et al., 1998) was kindly
provided by R. Axel. Genotypes of mice used in this study are as follows: wild-
type, Golf
wt/wt/Gs
flox/flox/OMACSwt/wt/rI7-CFP+, Golf-KO, Golf
//Gs
flox/flox/
OMACSwt/wt/rI7-CFP+, Gs-CKO, Golf
wt/wt/Gs
flox/flox/OMACSCre/wt or Cre/Cre/rI7-
CFP+, Golf-KO/Gs-CKO, and Golf
//Gs
flox/flox/OMACSCre/wt or Cre/Cre/rI7-
CFP+. Genotypes were determined by PCR.
All animal experiments were approved by the Animal Care Committee in the
University of Tokyo.
Quantitative RT-PCR
Quantitative PCR was performed as described previously (Takeuchi et al.,
2010). Expression levels of Nrp1, PlexinA1, Kirrel2, and Kirrel3 were normal-
ized to that of NCAM. Primer sets were designed by Universal Probe Library
(Roche) and Nihon Gene Research Laboratories. Primer sequences are in
the Supplemental Information.
Luciferase Assay
For the measurement of receptor activities, a luciferase assay was performed
as described (Saito et al., 2004, 2009; Tsuboi et al., 2011). Details are in the
Supplemental Information. All experiments were performed in triplicates,
and data represent mean ± SEM. Experiments were performed at least three
times, each with triplicate samples. We used Excel 2010 (Microsoft) and Prism
5 (GraphPad) software for statistical analyses and curve fitting. We used three
parameter Hill equations for curve fittings.
OR Gene Cloning
OR coding sequences were PCR amplified from genomic DNA or OE cDNA of
C57BL/6 mice and cloned into pME18S-F-R expression vector containing
N-terminal FLAG and rhodopsin tags. OR expression was driven by the
SRa promoter (Tsuboi et al., 2011). The sequence of N-terminal tag was
MDYKDDDDKEFMNGTEGPNFYLE. For the expression of ORs, 30 class II
OR genes (Zhang et al., 2004) were chosen, introduced into pME18S-F-R,
and transfected into HEK293 cells. OR nomenclatures were based on Zhang
and Firestein (2002). Gs and Golf sequences were PCR amplified from OE
cDNA. To generate OR::Gs and OR::Golf, a flexible linker sequence,
GGAGGA, was inserted into the junction of OR and G protein coding
sequences.
Odorant Exposure
MOR29B-YFP transgenic mice (Tsuboi et al., 2011) (hemizygotes in pure
C57BL/6 background) were kept in normal cages (26 3 40 3 18 cm) with
wood shavings until P21. In the vanillin-rich cages, 20 g solid powder of vanillin
(Wako) was placed in the bedding of each mouse cage. Mice were housed in
the control or vanillin-rich cages from P21 to P31. Littermates were analyzed in
the control experiments.
Experimental procedures for generation of coding swap mutant mice, histo-
chemistry, fluorescent signals, luciferase assay, quantification of cAMP, quan-
tification of cell surface ORs, naris occlusion, and immunocytochemistry are in
the Supplemental Information.CSUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
five figures and can be found with this article online at http://dx.doi.org/10.
1016/j.cell.2013.08.033.
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